Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 28 10:52AM ET
3.08
Dollar change
0.00
Percentage change
0.00
%
Index- P/E- EPS (ttm)-4.05 Insider Own3.78% Shs Outstand5.52M Perf Week3.36%
Market Cap17.16M Forward P/E6.16 EPS next Y0.50 Insider Trans0.00% Shs Float5.36M Perf Month4.05%
Income-18.00M PEG- EPS next Q-0.64 Inst Own31.78% Short Float6.75% Perf Quarter3.36%
Sales98.50M P/S0.17 EPS this Y56.36% Inst Trans- Short Ratio17.29 Perf Half Y60.42%
Book/sh5.90 P/B0.52 EPS next Y122.42% ROA-13.20% Short Interest0.36M Perf Year49.51%
Cash/sh3.51 P/C0.88 EPS next 5Y- ROE-45.75% 52W Range1.38 - 3.50 Perf YTD8.45%
Dividend Est.- P/FCF2.85 EPS past 5Y72.18% ROI-33.22% 52W High-12.00% Beta-1.21
Dividend TTM- Quick Ratio0.91 Sales past 5Y114.68% Gross Margin58.17% 52W Low123.19% ATR (14)0.17
Dividend Ex-Date- Current Ratio1.11 EPS Y/Y TTM95.70% Oper. Margin-5.71% RSI (14)57.75 Volatility5.45% 5.68%
Employees150 Debt/Eq0.96 Sales Y/Y TTM-6.71% Profit Margin-18.27% Recom1.00 Target Price8.00
Option/ShortNo / Yes LT Debt/Eq0.65 EPS Q/Q99.91% Payout- Rel Volume1.20 Prev Close3.08
Sales Surprise5.47% EPS Surprise84.00% Sales Q/Q-12.73% EarningsFeb 14 AMC Avg Volume20.92K Price3.08
SMA202.64% SMA506.61% SMA20028.68% Trades Volume6,636 Change0.00%
Date Action Analyst Rating Change Price Target Change
Mar-30-21Initiated Cantor Fitzgerald Overweight $11
May-29-20Initiated H.C. Wainwright Buy $3
Feb-16-24 08:27AM
Feb-15-24 05:49AM
Feb-14-24 04:05PM
Feb-07-24 04:15PM
Jan-23-24 09:00AM
07:00AM Loading…
Dec-06-23 07:00AM
Dec-05-23 07:00AM
Nov-30-23 08:00AM
Nov-15-23 09:44AM
Nov-14-23 04:05PM
Nov-08-23 08:30AM
Nov-07-23 04:15PM
Oct-26-23 08:00AM
Oct-09-23 04:15PM
Sep-28-23 08:18AM
04:20PM Loading…
Sep-27-23 04:20PM
Sep-21-23 08:25PM
Sep-13-23 08:00AM
Aug-09-23 10:26AM
07:43AM
Aug-08-23 09:15AM
Jul-31-23 08:00AM
Jul-10-23 08:00AM
Jun-14-23 08:00AM
Jun-13-23 01:45PM
Jun-09-23 08:00AM
May-16-23 11:51AM
May-11-23 04:25PM
04:05PM
May-04-23 04:30PM
08:00AM Loading…
May-01-23 08:00AM
Apr-27-23 08:00AM
Mar-06-23 09:55AM
Feb-23-23 04:33PM
Feb-21-23 04:10PM
03:00PM
Feb-14-23 08:00AM
Feb-07-23 08:00AM
Feb-06-23 10:57AM
Jan-25-23 08:00AM
Jan-24-23 08:00AM
Jan-10-23 08:00AM
Jan-05-23 04:01PM
Dec-29-22 06:01AM
Nov-30-22 08:00AM
Nov-22-22 04:05PM
Nov-17-22 08:58AM
08:00AM
Nov-16-22 08:00AM
05:59AM
Nov-14-22 04:05PM
Nov-07-22 04:01PM
Oct-25-22 08:00AM
Oct-13-22 10:57AM
08:00AM
Oct-05-22 08:00AM
Sep-27-22 04:30PM
04:05PM
Sep-20-22 08:00AM
Sep-14-22 08:00AM
Aug-24-22 08:00AM
Aug-16-22 08:00AM
Aug-15-22 04:01PM
Aug-09-22 09:15AM
Aug-08-22 04:01PM
Jul-26-22 08:00AM
Jul-20-22 08:00AM
Jun-29-22 08:00AM
Jun-13-22 08:00AM
May-17-22 07:29AM
May-16-22 04:02PM
Apr-25-22 08:00AM
Apr-19-22 08:00AM
Mar-23-22 08:00AM
Mar-22-22 08:00AM
Mar-08-22 08:00AM
Mar-07-22 04:05PM
Mar-02-22 08:00PM
08:00AM
Feb-18-22 09:40AM
Feb-14-22 04:05PM
Jan-31-22 08:00AM
Jan-04-22 08:00AM
Jan-03-22 08:00AM
Dec-14-21 09:30AM
Dec-13-21 08:00AM
Dec-09-21 11:38AM
Dec-08-21 08:00AM
Nov-23-21 08:00AM
Nov-17-21 08:00AM
Nov-15-21 04:00PM
Nov-08-21 08:05AM
Nov-04-21 03:01PM
Oct-04-21 04:49PM
Sep-30-21 08:01AM
Sep-29-21 06:49AM
Sep-27-21 04:01PM
Sep-23-21 08:00AM
Sep-09-21 08:00AM
Sep-08-21 07:00AM
Aytu Biopharma, Inc. is a specialty pharmaceutical company, which engages in identifying, acquiring, and commercializing novel products. It operates through the Rx and Consumer Health segments. The RX segment consists of various prescription pharmaceutical products sold through third parties. The Consumer Health segment includes various consumer health products sold directly to consumers. Its products include Adzenys ER, Adzenys XR-ODT, Cotempla XR-ODT, Karbinal ER, Poly-Vi-Flor, Tri-Vi-Flor, Generic Tussionex, Tuzistra XR, and ZolpiMist. The company was founded on August 9, 2002 and is headquartered in Englewood, CO.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
PYSZCZYMUKA GREGChief Commerical OfficerJun 16 '23Buy1.8712,00022,42821,935Jun 20 08:35 AM
Disbrow Joshua R.Chief Executive OfficerJun 14 '23Buy1.8614,00026,07971,591Jun 15 01:52 PM
PYSZCZYMUKA GREGChief Commerical OfficerApr 25 '23Option Exercise0.0083309,935Jun 20 08:29 AM